Europe
Clinical News
Informatics
Industry News
Practice Management
Education
Subspecialties
More
Sign In
CT
Digital X-Ray
Interventional
Molecular Imaging
MRI
Radiation Oncology/Therapy
Ultrasound
Womens Imaging
Nuclear Medicine: Page 365
Rise in procedure volume drives molecular imaging's growth
By
Jonathan S. Batchelor
Molecular imaging continues its rapid rise, spurred on by strong growth in procedure volume. Approximately 1 million PET procedures were performed in the U.S. in 2004 -- a 46% increase compared with the previous year. The increase in nuclear medicine utilization, particularly for cardiac imaging, has not escaped the notice of the U.S. Centers for Medicare and Medicaid Services (CMS).
November 2, 2005
Digirad shows Q3 loss
By
AuntMinnie.com staff writers
Nuclear medicine vendor Digirad reported fiscal 2005 third-quarter revenues of $17.4 million, up slightly compared with the $17.2 million turned in for the third quarter of 2004.
November 1, 2005
Thinking Systems adds University of Miami
By
AuntMinnie.com staff writers
PACS vendor Thinking Systems has installed its PACS product at the University of Miami's School of Medicine.
October 18, 2005
Scintimammography-SPECT valid as secondary test for ambiguous breast cancer
By
Shalmali Pal
Thus far, scintimammography's value has been proved in women with dense breasts or those who have breast cancer recurrence. Now researchers from Belgium have studied the impact of scintimammography in a clinical setting for women with inconclusive or contradictory results on routine breast imaging workup.
October 17, 2005
Oncologic PET/CT: A primer for radiologists
AuntMinnie.com is pleased to present this white paper by Dr. Stephen Humes for our members to download. This primer is intended as a succinct guide to practicing radiologists for interpretation of oncologic PET/CT images, as well as a quick reference when consulting with referring physicians as to the appropriateness of performing PET/CT to address a specific clinical question.
October 13, 2005
Draxis taps Brazier as COO
Canadian pharmaceutical developer Draxis Health has named Dan Brazier as its chief operating officer (COO).
October 3, 2005
Nitrates enhance tetrofosmin SPECT viability capabilities
By
Jonathan S. Batchelor
Establishing viable myocardial tissue is a crucial factor when considering patients with previous myocardial infarction and severe left ventricular dysfunction for coronary artery bypass grafting. A research team from Italy recently compared semiquantitative rest and postnitrate Tc-99m tetrofosmin SPECT with contrast-enhanced MRI (ceMRI) in detecting myocardial viability.
September 28, 2005
FDA issues draft CGMP for PET radiopharmaceuticals
By
AuntMinnie.com staff writers
The Food and Drug Administration has drafted a current good manufacturing practices (CGMP) regulation for the production of pharmaceuticals used in PET imaging, the agency reported.
September 25, 2005
ECR offers molecular imaging grant
By
AuntMinnie.com staff writers
The European Congress of Radiology (ECR) has announced the availability of a molecular imaging scholarship grant sponsored through the ECR/European Association of Radiology (EAR) research and education fund.
September 20, 2005
MDS Nordion to supply yttrium-90 to Berlex
By
AuntMinnie.com staff writers
Canadian radioisotope developer MDS Nordion of Kanata, Ontario, has been selected by Berlex Canada to supply yttrium-90 chloride sterile solution (Y-90) for use with Berlex's Zevalin radioimmunotherapy indicated for non-Hodgkin's lymphoma (NHL).
September 19, 2005
Digirad names imaging services chief
Nuclear medicine vendor Digirad of Poway, CA, has hired Mark Casner as the new president of its Digirad Imaging Services equipment-leasing subsidiary.
September 15, 2005
Horak leaves Immunomedics
By
AuntMinnie.com staff writers
Immunomedics executive vice president of research and development and chief scientific officer Dr. Ivan Horak has left the Morris Plains, NJ-based firm.
September 5, 2005
Previous Page
Page 365 of 437
Next Page